SCHEMBL965946

SCHEMBL965946

CCCCCCNC(C)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
TSHR P16473 3/20 0.47
LMNA P02545 2/20 0.47
MEN1 O00255 1/20 0.47
XBP1 P17861 1/20 0.47
KMT2A Q03164 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
ABCB11 O95342 1/20 0.47
EGFR P00533 1/20 0.47
ESR1 P03372 1/20 0.47
TP53 P04637 1/20 0.47
CYP1A2 P05177 1/20 0.47
FYN P06241 1/20 0.47
CHRM2 P08172 1/20 0.47
CHRM4 P08173 1/20 0.47
CYP3A4 P08684 1/20 0.47
HTR1A P08908 1/20 0.47
CHRM5 P08912 1/20 0.47
ADRA2A P08913 1/20 0.47
ADORA3 P0DMS8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15703396 1.00 ALDH1A1 (0.47) ALDH1A1TSHRLMNAMEN1XBP1
SCHEMBL16390107 1.00 ALDH1A1 (0.47) ALDH1A1TSHRLMNAMEN1XBP1
SCHEMBL2238633 1.00 ALDH1A1 (0.47) ALDH1A1TSHRLMNAMEN1XBP1
SCHEMBL10570528 1.00 ALDH1A1 (0.47) ALDH1A1TSHRLMNAMEN1XBP1
SCHEMBL380547 1.00 ALDH1A1 (0.47) ALDH1A1TSHRLMNAMEN1XBP1
SCHEMBL25021707 1.00 ALDH1A1 (0.47) ALDH1A1TSHRLMNAMEN1XBP1
SCHEMBL16389925 1.00 ALDH1A1 (0.47) ALDH1A1TSHRLMNAMEN1XBP1
SCHEMBL16390301 1.00 ALDH1A1 (0.47) ALDH1A1TSHRLMNAMEN1XBP1
SCHEMBL1464858 1.00 ALDH1A1 (0.47) ALDH1A1TSHRLMNAMEN1XBP1
SCHEMBL382199 1.00 ALDH1A1 (0.47) ALDH1A1TSHRLMNAMEN1XBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115832607-B Preparation method of battery diaphragm, battery diaphragm and secondary battery 宁德时代新能源科技股份有限公司 2024-10-18 CN claimed
CN-113620906-B Method for preparing ethylenediamine and ethanolamine derivatives by photocatalytic biomass polyalcohol 中国科学院大连化学物理研究所 2023-05-19 CN claimed
CN-115832607-A Preparation method of battery diaphragm, battery diaphragm and secondary battery 宁德时代新能源科技股份有限公司 2023-03-21 CN claimed
CN-113620906-A Method for preparing ethylenediamine and ethanolamine derivatives by photocatalysis of biomass polyols 中国科学院大连化学物理研究所 2021-11-09 CN claimed
US-10835524-B2 Compositions for the treatment of pancreatic cancer and uses thereof UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2020-11-17 US claimed
CN-108676313-A A kind of nonmetallic advertisement plank and its processing method 佛山市顺德区镒诚吸塑有限公司 2018-10-19 CN claimed
CN-104159977-B Thermoplastic resin composition 日本乳化剂株式会社 2017-09-12 CN claimed
CN-103459452-B Storage-stable polyurethane prepregs made of polyurethane compositions with liquid resin components and molded parts made therefrom EVONIK DEGUSSA GMBH (DE) 2016-11-30 CN claimed
US-7968507-B2 Composition for stripping and stripping method SAMSUNG ELECTRONICS CO., LTD. (KR) 2011-06-28 US claimed
US-20090084406-A1 Composition for stripping and stripping method SAMSUNG ELECTRONICS CO., LTD. 2009-04-02 US claimed
CN-101398639-A Composition for stripping and stripping method SAMSUNG ELECTRONICS CO LTD (KR) 2009-04-01 CN claimed
EP-0122151-B1 PRODUCTION OF PRIMARY OR SECONDARY ALCOHOL DERIVATIVES OF PHOSPHOLIPIDS BY THE ENZYMATIC TECHNIQUE MEITO SANGYO KABUSHIKI KAISHA (JP) 1989-02-15 EP claimed
EP-4747292-A1 NEW LATENT HARDENERS AND PU COMPOSITIONS CONTAINING THEM BASF SE (DE) 2026-05-27 EP disclosed
WO-2025017071-A1 NEW LATENT HARDENERS AND PU COMPOSITIONS CONTAINING THEM BASF SE (DE) 2025-01-23 WO disclosed
CN-115832607-B Preparation method of battery diaphragm, battery diaphragm and secondary battery 宁德时代新能源科技股份有限公司 2024-10-18 CN disclosed
US-11952493-B2 Moisture-curing polyurethane composition containing oxazolidine SIKA TECHNOLOGY AG (CH) 2024-04-09 US disclosed
US-4798897-A (AMINOALKYL)AMINOSULFONYL-SUBSTITUTED CARDIOVASCULAR AND RESPIRATORY SYSTEM DISORDERS ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1989-01-17 US disclosed
EP-0262378-A2 Process for the production of elastic essentially compact polyurethane mouldings with improved mould release properties BASF Aktiengesellschaft (DE) 1988-04-06 EP disclosed
US-4223138-A VAPORIZATION, CONDENSATION, RETARDING FLOW TO REACTION ZONE BAYER AKTIENGESELLSCHAFT (DE) 1980-09-16 US disclosed
US-3977994-A Rust inhibiting composition UNIVERSAL OIL PRODUCTS COMPANY (US) 1976-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10835524-B2 Compositions for the treatment of pancreatic cancer and uses thereof PIK3CA, MTOR, PIK3CD ALDH1A1 3902/4885TSHR 4358/4885LMNA 4327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.